Facebook
Linkedin
Mail
Twitter
Youtube
Home
Latest News
Features
Neuromodulation
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
Twitter
Youtube
NeuroNews International
Home
Latest News
Features
Neuromodulation
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Tag: pfizer
Biogen buys Pfizer’s unwanted neuro med for US$75M
13 March 2018
Biogen has bought a phase 2-ready schizophrenia drug. They will pay a US$75 million upfront for the therapy, with a follow-up payment of US$515...